Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Review

Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

Anthony D. Yang, Fan Fan, E. Ramsay Camp, George van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff and Lee M. Ellis
Anthony D. Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fan Fan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Ramsay Camp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George van Buren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenbiao Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ray Somcio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Gray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haiyun Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulo M. Hoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee M. Ellis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-06-0038 Published July 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Acquisition of oxaliplatin resistance induces morphologic changes consistent with EMT in CRC cells. KM12L4 (A) and HT29 (B) parental and OxR cells were assessed for morphologic changes consistent with EMT. Spindle-shaped cells with loss of polarity (red arrows), increased intercellular separation (green arrows), and pseudopodia (white arrows) were noted in the OxR cells but not in parental cells from both cell lines.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    OxR CRC cells have increased migratory and invasive capacity. Boyden chamber and modified Boyden chamber assays were done to compare the migratory and invasive capabilities of KM12L4 OxR and parental cells. A, at 48 hours, the OxR cells showed an ∼7.5-fold increase in the number of cells migrating through the collagen insert. B, also at 48 hours, the OxR cells exhibited an ∼15-fold increase in the number of cells invading through the Matrigel-coated collagen insert. HPF, high-power field; Ox, oxaliplatin.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    OxR CRC cells exhibit changes in localization of cellular EMT markers. Immunofluorescence staining for E-cadherin and β-catenin was done on KM12L4 (A) and HT29 (B) parental and OxR cells. OxR cells from both cell lines showed changes in localization of E-cadherin and β-catenin from their usual cell membrane-associated site. OxR cells exhibited E-cadherin in a disorganized cytoplasmic location and β-catenin was noted to translocate to the nucleus.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    OxR CRC cells exhibit molecular changes consistent with EMT. A, cell lysates and nuclear extracts from KM12L4 parental and OxR cells were subjected to Western blotting. Expression of the epithelial cellular adhesion molecules E-cadherin and plakoglobin was decreased in OxR cells compared with parental cells (top left). A marked increase in the expression of the mesenchymal marker vimentin was concurrently observed (top right). There was also increased expression of the EMT-related transcription factor Snail in nuclear extracts of OxR cells compared with parental cells (bottom). No change in expression of the EMT-related transcription factors Slug or Twist was noted. B, similar results were noted when validation studies were done in the HT29 parental and OxR cells (left) except that no up-regulation of mesenchymal markers was noted and no changes were noted in Snail, Slug, or Twist. However, nuclear expression of another transcription factor implicated in the induction of EMT, nuclear factor κB (NF-κB), was observed in the HT29 OxR cell line (right).

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    OxR CRC cells have reduced cell number. The cell number of KM12L4 (A) and HT29 (B) parental and OxR cells were compared by MTT assay. At 24, 48, and 72 hours, both the KM12L4 and HT29 OxR cells exhibited reduced cell number compared with the respective parental cells.

Tables

  • Figures
  • Table 1.

    Cell cycle analysis of KM12L4 and HT29 OxR cells

    48 hoursSub-G0 (%)G1 (%)S (%)G2 (%)
    KM12L4 parental11493813
    KM12 OxR8372934
    HT29 parental368248
    HT29 OxR3532720
PreviousNext
Back to top
Clinical Cancer Research: 12 (14)
July 2006
Volume 12, Issue 14
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
Anthony D. Yang, Fan Fan, E. Ramsay Camp, George van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff and Lee M. Ellis
Clin Cancer Res July 15 2006 (12) (14) 4147-4153; DOI: 10.1158/1078-0432.CCR-06-0038

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
Anthony D. Yang, Fan Fan, E. Ramsay Camp, George van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff and Lee M. Ellis
Clin Cancer Res July 15 2006 (12) (14) 4147-4153; DOI: 10.1158/1078-0432.CCR-06-0038
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • B7-H3: An Attractive Target for Antibody-based Immunotherapy
  • IL8 and NETs in Cancer Immunotherapy
  • 30 years of HER3
Show more Review
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement